Potential Impact of Parental Origin of Inheritance on the Clinical Presentation of Familial Partial Lipodystrophy Type 2 Syndrome
Clinical Endocrinology · 2025
DOI: 10.1111/cen.15303 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Endocrinology, 2025. Verfasst von Donatella Gilio und 12 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology and Diabetes Division, Department of Internal Medicine, Caswell Diabetes Institute and Metabolism, University of Michigan Medical Schoo…. Hauptthemen laut MEDLINE: Lipodystrophy, Familial Partial, Lamin Type A, Paternal Inheritance, Maternal Inheritance. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases (Grant 2R01DK125513), and Dokuz Eylul University-Research Fund (Project Number TUI-2023-3126)..
Abstract (Originalsprache)
Context
Familial partial lipodystrophy type 2 (FPLD2) is a rare autosomal dominant disorder caused by pathogenic variants in the LMNA gene. The influence of parental inheritance on clinical presentation has not been fully explored.
Objective
To investigate the influence of maternal versus paternal inheritance of LMNA variants on the clinical and metabolic phenotype of patients with FPLD2. Design, Patients, Measurements This retrospective cohort study included 83 patients with FPLD2 from four different centres. Clinical, biochemical, and body composition data were analysed. Patients were grouped based on maternal (maternal inheritance group; n = 49) or paternal (paternal inheritance group; n = 34) inheritance of LMNA variants. Statistical comparisons were made between the groups.
Results
Patients in the maternal inheritance group had a younger current age (35 (33) vs. 48 (22) years, p = 0.042) and earlier diagnosis of lipodystrophy (22 (30) vs. 36 (25) years, p = 0.044) compared to those in the paternal inheritance group. Body fat percentages in the arms (23.8 (6.5) % vs. 21.0 (6.2) %, p = 0.034) and trunk (32.1 (10.3) % vs. 28.5 (6.1) %, p = 0.024) were higher in maternal inheritance group. Fatty liver disease (79% vs. 57%, p = 0.029) and pancreatitis (26% vs. 8%, p = 0.033) were more prevalent in paternal inheritance group.
Conclusion
Parental lineage may influence the phenotype of FPLD2: patients with a maternally inherited LMNA variant tend to preserve more adipose tissue in the upper body, while those with a paternally inherited variant experience greater adipose tissue loss in that region, often associated with more severe metabolic complications. These findings highlight the importance of contemplating parental lineage as a relevant factor when evaluating the clinical presentation and management of patients with FPLD2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrinology and Diabetes Division, Department of Internal Medicine, Caswell Diabetes Institute and Metabolism, University of Michigan Medical School, Ann Arbor, Michigan, USA.
- Department of Clinical and Translational Sciences, University of Pisa, Pisa, Italy.
- Endocrinology Unit, Obesity and Lipodystrophy Center, University Hospital of Pisa, Pisa, Italy.
- Division of Pediatric Endocrinology, Dokuz Eylul University, Izmir, Türkiye.
- Division of Internal Medicine, University of São Paulo, Ribeirão Preto, Brazil.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Ege University, Izmir, Türkiye.
ORCID-Profile: Merve Celik Guler, Baris Akinci, Elif A Oral
Förderung
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases (Grant 2R01DK125513), and Dokuz Eylul University-Research Fund (Project Number TUI-2023-3126).
Zitieren
APA
Gilio, D., Besci, O., Guidorizzi, N. R., Guler, M. C., Simsir, I. Y., Pelosini, C., Ceccarini, G., Demir, K., Akinci, B., Santini, F., ECLip (European Consortium of Lipodystrophy), Foss-Freitas, M. C., & Oral, E. A. (2025). Potential Impact of Parental Origin of Inheritance on the Clinical Presentation of Familial Partial Lipodystrophy Type 2 Syndrome. Clinical Endocrinology. https://doi.org/10.1111/cen.15303
Vancouver
Gilio D, Besci O, Guidorizzi NR, Guler MC, Simsir IY, Pelosini C, et al. Potential Impact of Parental Origin of Inheritance on the Clinical Presentation of Familial Partial Lipodystrophy Type 2 Syndrome. Clinical Endocrinology. 2025. doi:10.1111/cen.15303
BibTeX
@article{Gilio2025,
author = {Gilio, Donatella and Besci, Ozge and Guidorizzi, Natália Rossin and Guler, Merve Celik and Simsir, Ilgin Yildirim and Pelosini, Caterina and Ceccarini, Giovanni and Demir, Korcan and Akinci, Baris and Santini, Ferruccio and ECLip (European Consortium of Lipodystrophy), ECLip (European Consortium of Lipodystrophy) and Foss-Freitas, Maria Cristina and Oral, Elif A},
title = {Potential Impact of Parental Origin of Inheritance on the Clinical Presentation of Familial Partial Lipodystrophy Type 2 Syndrome},
journal = {Clinical Endocrinology},
year = {2025},
doi = {10.1111/cen.15303}
}
EUVIMED